Overview

Efficacy and Safety of Magnólia Nasal Gel in the Treatment of Allergic Rhinitis

Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Magnólia nasal gel in the treatment of moderate-severe persistent or moderate-severe intermittent allergic rhinitis.
Phase:
Phase 3
Details
Lead Sponsor:
EMS
Treatments:
Mometasone Furoate